• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠胰神经内分泌肿瘤患者临床病理特征与临床预后的相关性

Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors.

作者信息

Fan Dongwei, Li Xuanhe, Yu Yousheng, Wang Xingliang, Fang Jun, Huang Cheng

机构信息

Department of General Surgery, Affiliated Hospital of West Anhui Health Vocational College, Lu'an, Anhui 237000, P.R. China.

Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233000, P.R. China.

出版信息

Mol Clin Oncol. 2023 Sep 13;19(5):85. doi: 10.3892/mco.2023.2681. eCollection 2023 Nov.

DOI:10.3892/mco.2023.2681
PMID:37809346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10557094/
Abstract

Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) are one of the most common types of NETs, accounting for 65-75% of all NETs. However, epidemiological characteristics of patients with GEP-NETs in China are still lacking. The present retrospective study aimed to investigate the local epidemiology of GEP-NETs and assess the prognostic factors in China. The data of 267 patients with GEP-NETs who were admitted to the First Affiliated Hospital of Bengbu Medical College (Bengbu, China) and the Affiliated Hospital of West Anhui Health Vocational College (Lu'an, China) were retrospectively reviewed. The clinical and pathological characteristics of the patients, as well as follow-up information, were collected, and the 5-year survival rate was calculated. Kaplan-Meier curves and log-rank analysis were used to analyze the prognostic factors. The stomach (100/267; 37.5%) was the most common site of GEP-NETs and the liver (25/39; 64.1%) was the most common metastatic site. A total of 166 (62.2%) and 219 (82.0%) patients had positive results for chromogranin A (CgA) and synaptophysin (Syn), respectively. The percentage of patients with tumor grade G1, G2 and G3 was 33.3, 21.0 and 45.7%, respectively. The 5-year overall survival rate was 79.7%, and the age, tumor site, distant metastasis and tumor grading upon diagnosis were all prognostic factors. In conclusion, the present case series investigated the epidemiology and prognostic factors of GEP-NETs in China. CgA and Syn could be used as diagnostic markers for NETs and the stomach was the most common primary tumor site. Lymph node metastasis, tumor site, distant metastasis and tumor grading were important prognostic factors.

摘要

胃肠胰(GEP)神经内分泌肿瘤(NETs)是最常见的NETs类型之一,占所有NETs的65 - 75%。然而,中国GEP - NETs患者的流行病学特征仍不明确。本回顾性研究旨在调查中国GEP - NETs的局部流行病学情况并评估预后因素。回顾性分析了蚌埠医学院第一附属医院(中国蚌埠)和皖西卫生职业学院附属医院(中国六安)收治的267例GEP - NETs患者的数据。收集患者的临床和病理特征以及随访信息,并计算5年生存率。采用Kaplan - Meier曲线和对数秩检验分析预后因素。胃(100/267;37.5%)是GEP - NETs最常见的原发部位,肝(25/39;64.1%)是最常见的转移部位。共有166例(62.2%)和219例(82.0%)患者的嗜铬粒蛋白A(CgA)和突触素(Syn)检测结果呈阳性。肿瘤分级为G1、G2和G3的患者比例分别为33.3%、21.0%和45.7%。5年总生存率为79.7%,诊断时的年龄、肿瘤部位、远处转移和肿瘤分级均为预后因素。总之,本病例系列研究了中国GEP - NETs的流行病学和预后因素。CgA和Syn可作为NETs的诊断标志物,胃是最常见的原发肿瘤部位。淋巴结转移、肿瘤部位、远处转移和肿瘤分级是重要的预后因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/10557094/aeca4d6cd62c/mco-19-05-02681-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/10557094/f6008a4d3e95/mco-19-05-02681-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/10557094/aeca4d6cd62c/mco-19-05-02681-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/10557094/f6008a4d3e95/mco-19-05-02681-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/85d2/10557094/aeca4d6cd62c/mco-19-05-02681-g01.jpg

相似文献

1
Correlation between clinicopathological characteristics and the clinical prognosis of patients with gastroenteropancreatic neuroendocrine tumors.胃肠胰神经内分泌肿瘤患者临床病理特征与临床预后的相关性
Mol Clin Oncol. 2023 Sep 13;19(5):85. doi: 10.3892/mco.2023.2681. eCollection 2023 Nov.
2
Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.中国人群胃肠胰神经内分泌肿瘤的临床病理特征及预后:一项大型回顾性单中心研究
BMC Endocr Disord. 2017 Jul 13;17(1):39. doi: 10.1186/s12902-017-0190-6.
3
Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.中国患者胃肠胰混合性神经内分泌-非神经内分泌肿瘤的临床病理特征及预后因素
World J Gastroenterol. 2021 Feb 21;27(7):624-640. doi: 10.3748/wjg.v27.i7.624.
4
Clinical Features and Long-Term Survival of Metastatic Hepatic Neuroendocrine Neoplasms Secondary to Gastroenteropancreatic Site: An Analysis by Applying the Grading Classification.胃肠胰部位继发的转移性肝神经内分泌肿瘤的临床特征及长期生存:应用分级分类法的分析
J Oncol. 2020 Sep 15;2020:6572398. doi: 10.1155/2020/6572398. eCollection 2020.
5
Risk factors, prognostic factors, and nomograms for distant metastases in patients with gastroenteropancreatic neuroendocrine tumors: a population-based study.胃肠胰神经内分泌肿瘤患者远处转移的风险因素、预后因素和列线图:一项基于人群的研究。
Front Endocrinol (Lausanne). 2024 Feb 14;15:1264952. doi: 10.3389/fendo.2024.1264952. eCollection 2024.
6
Relationship between clinical characteristics and survival of gastroenteropancreatic neuroendocrine neoplasms: A single-institution analysis (1995-2012) in South China.胃肠胰神经内分泌肿瘤的临床特征与生存的关系:华南单机构分析(1995-2012 年)。
BMC Endocr Disord. 2012 Nov 29;12:30. doi: 10.1186/1472-6823-12-30.
7
[Pathological characteristics and survival analysis of 355 patients with gastroenteropancreatic neuroendocrine neoplasms].355例胃肠胰神经内分泌肿瘤患者的病理特征及生存分析
Zhonghua Zhong Liu Za Zhi. 2020 May 23;42(5):426-431. doi: 10.3760/cma.j.cn112152-112152-20191011-00663.
8
Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.胃肠胰神经内分泌肿瘤的临床病理特征与预后:一项中国南方的多中心研究
Chin J Cancer. 2017 Jun 21;36(1):51. doi: 10.1186/s40880-017-0218-3.
9
Sex comb on midleg like-2 is a novel specific marker for the diagnosis of gastroenteropancreatic neuroendocrine tumors.中腿性梳样蛋白-2是诊断胃肠胰神经内分泌肿瘤的一种新型特异性标志物。
Exp Ther Med. 2017 Aug;14(2):1749-1755. doi: 10.3892/etm.2017.4677. Epub 2017 Jun 26.
10
Epidemiologic Trends of and Factors Associated With Overall Survival for Patients With Gastroenteropancreatic Neuroendocrine Tumors in the United States.美国胃肠胰神经内分泌肿瘤患者总体生存的流行病学趋势及相关因素。
JAMA Netw Open. 2021 Sep 1;4(9):e2124750. doi: 10.1001/jamanetworkopen.2021.24750.

引用本文的文献

1
Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study.转移性直肠癌患者生存结局与肿瘤位置及预后因素的关系:一项多中心回顾性队列研究
Front Oncol. 2024 Jun 14;14:1363305. doi: 10.3389/fonc.2024.1363305. eCollection 2024.

本文引用的文献

1
Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms.《2022 年世卫组织神经内分泌肿瘤分类概述》。
Endocr Pathol. 2022 Mar;33(1):115-154. doi: 10.1007/s12022-022-09708-2. Epub 2022 Mar 16.
2
Neuroendocrine Tumors: a Relevant Clinical Update.神经内分泌肿瘤:相关临床进展
Curr Oncol Rep. 2022 Jun;24(6):703-714. doi: 10.1007/s11912-022-01217-z. Epub 2022 Mar 7.
3
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.神经内分泌和肾上腺肿瘤,第2.2021版,美国国立综合癌症网络(NCCN)肿瘤学临床实践指南
J Natl Compr Canc Netw. 2021 Jul 28;19(7):839-868. doi: 10.6004/jnccn.2021.0032.
4
Neuroendocrine neoplasms of the esophagus and stomach.食管和胃的神经内分泌肿瘤。
Pathologica. 2021 Feb;113(1):5-11. doi: 10.32074/1591-951X-229.
5
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.神经内分泌肿瘤的分子成像与治疗共识。
Eur J Cancer. 2021 Mar;146:56-73. doi: 10.1016/j.ejca.2021.01.008. Epub 2021 Feb 12.
6
[Chinese consensus on the pathological diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasms(2020)].《中国胃肠胰神经内分泌肿瘤病理诊断共识(2020年版)》
Zhonghua Bing Li Xue Za Zhi. 2021 Jan 8;50(1):14-20. doi: 10.3760/cma.j.cn112151-20200805-00623.
7
Prospective Evaluation of the NETest as a Liquid Biopsy for Gastroenteropancreatic and Bronchopulmonary Neuroendocrine Tumors: An ENETS Center of Excellence Experience.前瞻性评估 NETest 作为胃肠胰和支气管肺神经内分泌肿瘤的液体活检:ENETS 卓越中心的经验。
Neuroendocrinology. 2021;111(4):304-319. doi: 10.1159/000508106. Epub 2020 Apr 24.
8
A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood.一项关于血液中神经内分泌肿瘤 mRNA 基因组生物标志物 (NETest) 准确性的荟萃分析。
Ann Oncol. 2020 Feb;31(2):202-212. doi: 10.1016/j.annonc.2019.11.003. Epub 2019 Dec 20.
9
Gastroenteropancreatic Neuroendocrine Tumors.胃肠胰神经内分泌肿瘤。
CA Cancer J Clin. 2018 Nov;68(6):471-487. doi: 10.3322/caac.21493. Epub 2018 Oct 8.
10
Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.评估 NETest 在一项基于美国注册研究中的临床效用。
Oncologist. 2019 Jun;24(6):783-790. doi: 10.1634/theoncologist.2017-0623. Epub 2018 Aug 29.